Fig. 5.
Fig. 5. Effect of (A) staurosporine and (B) the protein kinase A inhibitor H89 on eosinophil aggregation induced by PAF, C5a, or LTB4 . Eosinophils were pretreated for 3 minutes with vehicle (▪), staurosporine (10−7 mol/L; □), or H89 (10−5 mol/L; □) before the addition of PAF (10−8 mol/L), C5a (10−7 mol/L), or LTB4 (10−8 mol/L). Results are expressed as the percentage of maximal aggregation induced by PMA (10−7 mol/L) and each point is the mean ± SEM for four experiments. *P < .05 when compared with control values.

Effect of (A) staurosporine and (B) the protein kinase A inhibitor H89 on eosinophil aggregation induced by PAF, C5a, or LTB4 . Eosinophils were pretreated for 3 minutes with vehicle (▪), staurosporine (10−7 mol/L; □), or H89 (10−5 mol/L; □) before the addition of PAF (10−8 mol/L), C5a (10−7 mol/L), or LTB4 (10−8 mol/L). Results are expressed as the percentage of maximal aggregation induced by PMA (10−7 mol/L) and each point is the mean ± SEM for four experiments. *P < .05 when compared with control values.

Close Modal

or Create an Account

Close Modal
Close Modal